Latest News

Latest News

News from the World Hepatitis Alliance

An open letter to the Cochrane Collaboration

26 Jun 2017 Bridie Taylor

The members of the Executive Board of the World Hepatitis Alliance are elected to represent the more than 300 million people who have the experience...

“Findings from hepatitis C study should not deter patients from seeking treatment or governments from funding it” says World Hepatitis Alliance

13 Jun 2017 Tara Farrell

The World Hepatitis Alliance is concerned that the findings of the Cochrane Review on the new direct acting antiviral (DAA) hepatitis C drugs could...

World Hepatitis Alliance seeks Communications and Campaigns Officer

9 Jun 2017 Tara Farrell

Our dynamic Communications team is seeking an experienced Communications and Campaigns Officer to develop and implement our external facing...

Why do we continue to put our children at unnecessary risk of liver cancer?

6 Jun 2017 Bridie Taylor

On International Children’s Day (1June), the World Hepatitis Alliance calls for widespread coverage of the hepatitis B birth dose vaccine to protect...

WHO’s first Global Hepatitis Report sets baseline to measure progress towards the elimination of viral hepatitis by 2030

21 Apr 2017 Tara Farrell

London, 21 April 2017, The World Hepatitis Alliance today welcomes the publication of the first-ever Global Hepatitis Report by the World Health Organization (WHO). The report comes as a follow-up to WHO’s Global Strategy on Viral Hepatitis, which set a goal of eliminating viral hepatitis as a public health threat by 2030....

ZERO DISCRIMINATION DAY: FEAR AND IGNORANCE ROBS PEOPLE OF JOBS, EDUCATION OPPORTUNITIES, FRIENDSHIPS AND RELATIONSHIPS

1 Mar 2017 Bridie Taylor

People living with viral hepatitis are subject to stigma and discrimination in almost every aspect of their lives. Fear and ignorance have robbed...

World Day of Social Justice: fighting for our right to health

20 Feb 2017 Tara Farrell

By Raquel Peck By the time you finish reading this blog, a man, woman or child will have died from viral hepatitis; a disease which can either be...

World Hepatitis Alliance President-Elect announced

26 Jan 2017 Bridie Taylor

Michael Ninburg appointed as WHA President-Elect Today, the World Hepatitis Alliance (WHA) Executive Board announced that, following a comprehensive...

Elimination to take centre stage at APASL 2017

24 Jan 2017 Bridie Taylor

The elimination of viral hepatitis to dominate discussions at the 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL...

Industry and civil Society unite to help deliver hepatitis C medication in low-and middle-income countries

18 Jan 2017 Tara Farrell

Today, MasterCard signed a Memorandum of Understanding (MoU) with Gilead Sciences, Inc. to explore, in a pilot programme, the potential of using the...

India’s young filmmakers give a global voice to viral hepatitis survivors

14 Dec 2016 Tara Farrell

Today, media charity tve today launches four powerful films that give voice to five individuals in India who have survived viral hepatitis, one of...

Leave no-one behind

2 Dec 2016 Tara Farrell

On 3rd December, patients across the globe will unite to mark Patient Solidarity Day and reaffirm that patient-centred universal health coverage is...

HIV coinfection more than triples the risk of liver disease, liver failure and liver-related death from viral hepatitis

1 Dec 2016 Bridie Taylor

On World AIDS Day, the World Hepatitis Alliance calls for increased recognition of viral hepatitis and HIV coinfections London, 1 December 2016 –...

New WHA Executive Board announced

28 Nov 2016 Bridie Taylor

Our voting members have spoken and the votes have been counted! Following a fiercely contested election, we are delighted to announce our new...

WHO launches first-ever global report on access to hepatitis C treatment

27 Oct 2016 Tara Farrell

New report from the World Health Organization (WHO) released today shows how political will, civil society advocacy and pricing negotiations are...

Launch of World Hepatitis Day 2016 Report

19 Oct 2016 Tara Farrell

On 28 July 2016, patients, governments, organisations and many others participated the most successful World Hepatitis Day (WHD) to date, with 174...

New database sheds light on generic hep C drugs in low-and middle-income countries and how to access them

13 Oct 2016 Bridie Taylor

To provide information on the intellectual property status of priority medicines in 101 low-and middle-income countries, the Medicines Patent Pool (...

Interested in leading a global organisation in the fight to eliminate viral hepatitis?

15 Sep 2016 Bridie Taylor

The World Hepatitis Alliance (WHA) is seeking nominations for two key offices; President-Elect and Regional Executive Board Members, to drive action...

Europe Adopts Regional Action Plan to Eliminate Viral Hepatitis

14 Sep 2016 Tara Farrell

Today, representatives from the 53 countries in the WHO European Region adopted the first-ever Action Plan for viral hepatitis. The Action Plan,...

CHANGE OF DATE: WORLD HEPATITIS SUMMIT 2017

12 Sep 2016 Tara Farrell

Due to unforeseen circumstances, the Committee of the World Hepatitis Summit - comprising the World Hepatitis Alliance; World Health Organization and...

Pages

News from infohep

US regulator approves Gilead's Vosevi combo pill for hepatitis C retreatment

19 Jul 2017 Liz Highleyman
On 18 July the US Food and Drug Administration (FDA) approved Gilead Sciences' Vosevi, a new once-daily combination pill containing sofosbuvir,...

Non-alcoholic fatty liver disease common in people living with HIV – metabolic disorders are key risk factors

19 Jul 2017 Michael Carter
Over a third of people with HIV have non-alcoholic fatty liver disease (NAFLD) in the absence of hepatitis B or C, according to the results of a meta...

HCV therapy with SVR reduces the risk of several non-liver-related diseases commonly seen in people with chronic HCV

6 Jul 2017 Michael Carter
The risk of several non-liver complications associated with chronic hepatitis C virus (HCV) infection is reduced after interferon-based treatment...

San Francisco task force releases first hepatitis C estimates

4 Jul 2017 Liz Highleyman
End Hep C SF, a consortium of public health workers, medical providers, advocates and people living with hepatitis C, has released the first-ever...

Hepatitis A outbreak in gay and bisexual men in Europe is growing

3 Jul 2017 Keith Alcorn
New cases of hepatitis A cases have soared in Western Europe over the past six months as a result of an epidemic in gay and bisexual men, the...

New pangenotypic hepatitis C drug combinations recommended for approval in the European Union

26 Jun 2017 Keith Alcorn
Two new pangenotypic direct-acting antiviral combinations have received positive opinions from the scientific committee of the European Medicines...

Experts question Cochrane review of hepatitis C treatment

15 Jun 2017 Keith Alcorn
A systematic review of hepatitis C direct-acting antiviral (DAA) studies published by the Cochrane Collaboration has been strongly criticised by...

Six-question risk score can identify HIV-positive gay men needing testing for acute hepatitis C

13 Jun 2017 Roger Pebody
Six questions can identify HIV-positive gay men who are at elevated risk of having acute (recent) hepatitis C infection and who would benefit from...

Sofosbuvir plus ribavirin cures teens with genotype 2 or 3 hepatitis C

5 Jun 2017 Liz Highleyman
A two-drug regimen of sofosbuvir (Sovaldi) and ribavirin taken for 12 weeks led to sustained virological response in all treated adolescents with...

Indonesian buyers club helps people obtain generic hepatitis C treatment

30 May 2017 Liz Highleyman
A community-led buyers club in Indonesia has helped more than 100 people get generic direct-acting antiviral (DAA) drugs to treat hepatitis C and is...